Mutating strains and newly emerging viruses: how can one drug protect against future pandemics?

While advances in COVID-19 vaccines are being released thick and fast, 42% of Americans polled recently indicated that they may not agree to receive the vaccine. In combination with a number of other factors, this means that to successfully overcome COVID-19 we will need effective treatments for the disease to accompany the vaccines. With viral pathogens continually mutating and changing, achieving long-lasting vaccines and continually effective therapeutics is easier said than done, but Laura Walker, Chief Scientific Officer at Adagio Therapeutics (MA, USA), thinks her team may have found the answer. Here, Laura takes us through Adagio’s broadly neutralizing antibody...